
Neogen Corporation NEOG
€ 7.66
-2.41%
Quartalsbericht 2026-Q1
hinzugefügt 09.04.2026
Neogen Corporation DSO 2011-2026 | NEOG
DSO Jährlich Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.6 | 64.4 | 56.1 | 66.3 | 68.8 | 73 | 72.8 | 71.8 | 69.2 | 76.9 | 76.3 | 76.6 | 68.1 | 70.7 | 60.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 76.9 | 56.1 | 69.2 |
DSO Vierteljährlich Neogen Corporation
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.1 | 54.9 | 63.7 | - | 66.9 | 65.5 | 71.6 | - | 64.6 | 57.3 | 58 | - | 60.4 | 46.8 | 66.5 | 24.3 | 66 | 62.9 | 63.7 | 32.4 | 67.1 | 62.5 | 67.8 | 65.6 | 75.9 | 69.6 | 72.7 | 69.9 | 74.2 | 68.3 | 72 | 67.4 | 73.2 | 63.3 | 64.6 | 31.8 | 68.9 | 62.5 | 69.3 | 68 | 68.3 | 66.8 | 72.1 | 67.9 | 67.8 | 69.2 | 69.9 | 69.2 | 65.9 | 68.5 | 64.2 | 59.3 | 59.5 | 67.7 | 67.3 | 64.1 | 62 | 65.6 | 61.2 | 58.2 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 75.9 | 24.3 | 63.7 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 5.63 | -2.26 % | $ 7.49 M | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 21.01 | -2.73 % | $ 609 M | ||
|
Fulgent Genetics
FLGT
|
87 | $ 19.15 | -1.79 % | $ 589 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
72.7 | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
46.1 | $ 125.61 | -5.6 % | $ 15.7 B | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.67 | -6.7 % | $ 7.39 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Illumina
ILMN
|
66.8 | $ 162.32 | -3.42 % | $ 25.2 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 22.25 | -3.76 % | $ 1.19 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 149.45 | -2.19 % | $ 11.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 100.98 | -1.79 % | $ 6.82 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 10.9 | -3.63 % | $ 1.4 B | ||
|
Natera
NTRA
|
48.3 | $ 215.31 | -3.06 % | $ 29.4 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 181.34 | -2.4 % | $ 8.99 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
71.8 | $ 1.45 | -11.04 % | $ 435 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 454.25 | -0.97 % | $ 13.1 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 154.33 | -2.22 % | $ 23.8 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.57 | -2.56 % | $ 423 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.14 | -3.09 % | $ 428 M | ||
|
Personalis
PSNL
|
63.8 | $ 10.75 | -11.16 % | $ 959 M | ||
|
Senseonics Holdings
SENS
|
1.04 | $ 6.67 | -4.85 % | $ 278 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
27 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.12 | -1.17 % | $ 4.87 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 265.15 | 1.6 % | $ 22.1 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 69.22 | -6.37 % | $ 4.14 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 472.8 | -1.91 % | $ 178 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.67 | -2.43 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
306 | $ 365.36 | -2.95 % | $ 21.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 200.29 | 2.13 % | $ 22.2 B |